United Therapeutics is the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter's pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease (ALD) Specialist maintains and increases sales of all UT products, with a primary focus on Tyvaso, assigned within a defined territory of targeted physicians and key accounts through effective territory management and execution of sales/marketing strategies. Serves as an important educational resource for all physicians and other healthcare professionals (HCP's) involved in the treatment of PH-ILD and/or IPF. Promote marketed products according to corporate guidance in an assigned geographic territory and designated accounts to actively interface with the PH-ILD and IPF community Build and maintain professional relationships with various customer types (MDs, NPs, PAs, RNs, and specialty distributor staff) to ensure maximal product messaging and education on assigned UT products, which include: Tyvaso, and according to package insert Analyze sales reports and develop and implement business plans to increase business and drive sales in key accounts, achieving or exceeding target sales goals Coordinate activities with other field-based team members (including RBD, and other field-based personnel to optimize selling, education and support efforts) Appropriately and effectively utilize available resources to drive sales with key customers Develop and maintain expert knowledge of disease state, product, and competitive landscape Utilize sales force automation system to maximize territory effectiveness and record-keeping Complete all UT administrative requirements in a timely manner, including but not limited to expense reports and call reporting (with all reporting requirements as outlined in UT Commercial Compliance Guidelines) Adhere to all corporate, external regulatory, and UT guidelines related to the promotion of our products Attend local/regional/national medical PH-ILD and/or IPF symposia and conferences in order to provide education and promotion support to key stakeholders in attendance and to enhance understanding of treatment trends Attend patient support group meetings and remain current with PH-ILD and/or IPF community in accordance with our PHA's guidelines regarding support group interaction; participate (as directed) in project teams with sales and marketing teams to establish programs and resources to increase sales and awareness Territory to include: Manhattan, Southern Manhattan, NY- Newark, Hackensack, NJ
Bachelor's Degree (preferably in nursing or life science), or equivalent experience 6+ years of experience successfully selling pharmaceutical therapies or similar products to specialty physicians, nurses and other healthcare professionals (i.e., cardiologists, pulmonologists, etc.) OR 6+ years of healthcare/nursing experience with advanced lung disease 2+ years of experience with Cardiovascular and/or Pulmonary Disease Therapeutics areas Expertise in Cardiovascular and/or Pulmonary Disease therapeutic area Strong leader with proven selling record and outstanding communication skills Demonstrated decision-making ability, planning and interpersonal skills Develop and maintain complete knowledge of UT products and services Valid Driver's License in good standing
2+ years of experience in specialty pharmaceutical/biotech sales 2+ years of experience in PH-ILD and/or IPF sales 2+ years of experience selling within institutional or major teaching centers environment
This position is located remotely within the Southern Manhattan, New York City area with ideal candidates living within the territory being supported. This position requires 75-80% travel, including reaching territory for direct customer interaction via face-to-face meetings/visits, going into UT Offices, as well as national events and conferences. Candidates must be able to travel via motor vehicle and/or airplane. Final interviews will be conducted in person at select locations across the U.S. during April and May 2026. Candidates invited to the final round may be asked to travel, with applicable travel arrangements coordinated by United Therapeutics.
The salary for the ALD Specialist is from $130,000 to $160,000 per year and the salary for the Sr. ALD Specialist is from $155,000 to $180,000 per year. These ranges reflect our good-faith estimate of the compensation for these roles at the time of posting. This range represents base salary only and does not reflect total compensation, which provides opportunity for competitive sales incentive compensation, long-term incentives, and a comprehensive benefits package. An employee's position within the salary range will be based on factors such as education, qualifications, experience, skills, geographic location, and business needs, as well as other factors permitted by law at the time of posting. This range may be modified in the future based on company and market factors.